Inhibition of growth of the apicomplexan parasite Toxoplasma gondii by aryloxyphenoxypropionate herbicides has been correlated with the inhibition of its acetyl-CoA carboxylase (ACC) by these compounds. Here, full-length and C-terminal fragments of T. gondii apicoplast ACC as well as C-terminal fragments of the cytosolic ACC were expressed in E. coli.
SUMMARY
Inhibition of growth of the apicomplexan parasite Toxoplasma gondii by aryloxyphenoxypropionate herbicides has been correlated with the inhibition of its acetyl-CoA carboxylase (ACC) by these compounds. Here, full-length and C-terminal fragments of T. gondii apicoplast ACC as well as C-terminal fragments of the cytosolic ACC were expressed in E. coli.
The recombinant proteins that were soluble showed the expected enzymatic activities. Yeast gene-replacement strains depending for growth on the expressed T. gondii ACC were derived by complementation of a yeast ACC1 null mutation. In vitro and in vivo tests with aryloxyphenoxypropionates showed that the carboxyltransferase domain of the apicoplast T.
gondii ACC is the target for this class of inhibitors. The cytosolic T. gondii ACC is resistant to aryloxyphenoxypropionates. Both T. gondii isozymes are resistant to cyclohexanediones, another class of inhibitors targeting the ACC of grass plastids.
INTRODUCTION
New treatments for human and animal apicomplexan pathogens are needed. Parasites of this phylum, including Plasmodium, Toxoplasma, Cryptosporidium and Eimeria species cause serious diseases in humans as well as in animals. Identifying candidate drugs either for a standalone or combination therapy requires characterization of key metabolic pathways in apicomplexan parasites, including their enzymology and subcellular localization. The basic molecular and cellular mechanisms are likely to be similar in all Apicomplexa. However, a significant divergence of these species with respect to protein structure, physiology and host range point to potential variability in the effectiveness and specificity of inhibitors targeting any particular enzyme. The metabolic pathways located in the apicoplast, a plastid-like organelle found in Apicomplexa (1-3), may have significantly distinct features to allow identification of specific antiparasitic inhibitors harmless to the host (4) . Although the function of the apicoplast is not fully understood, it has been suggested to be the site of such pathways as the biosynthesis of isoprenoids, heme, aromatic amino acids and fatty acids (1) (2) (3) (4) (5) . Apicoplast localization of essential enzymes of the fatty acid biosynthetic pathway, acetyl-CoA carboxylase (ACC) (6) and acyl carrier protein (7) in T. gondii, and acyl carrier protein and β-ketoacyl-ACP synthase III in P. falciparum (7, 8) , supports the hypothesis that the apicoplast is a site of de novo fatty acid biosynthesis.
ACC catalyzes carboxylation of acetyl-CoA to produce malonyl-CoA (full reaction). The enzyme consists of three major functional domains: the biotin carboxylase (BC) domain, the carboxyltransferase (CT) domain and the biotin carboxyl carrier (BCC) domain containing covalently attached biotin. The first step of the ACC-catalyzed reaction is an ATP-dependent transfer of the carboxyl group from bicarbonate to the biotin residue (first half-reaction). The carboxyl group is then transferred to acetyl-CoA producing malonyl-CoA (second halfreaction). Malonyl-CoA is used for de novo fatty acid biosynthesis as well as in fatty acid elongation.
Our previous study of ACC and its genes in T. gondii (6, 9) showed the existence of two isozymes: one located in the apicoplast (ACC1) and the other in the cytosol (ACC2). ACC1 and ACC2 are both of the multi-domain type (all functional domains in one polypeptide) found in the Inhibition of Toxoplasma gondii acetyl-CoA carboxylase Jelenska et al. cytosol of eukaryotes and in plastids of some plants. Genes encoding multi-domain ACC have been found in other Apicomplexa as well (9) . We postulated that the apicoplast isozyme is involved in Toxoplasma de novo fatty acid biosynthesis (6) . The role of the cytosolic isozyme is not yet clear. The major Toxoplasma ACC activity is sensitive to aryloxyphenoxypropionates (fops) but resistant to cyclohexanediones (dims) (9) . These two classes of compounds are herbicides targeting the multi-domain plastid ACC, inhibiting fatty acid biosynthesis in sensitive grasses (10) (11) (12) (13) . We have localized the herbicide sensitivity determinant to a 400-amino acid fragment of the carboxyltransferase (CT) domain (14) and showed that the second ACC halfreaction is affected (15) . We have also shown that a single highly conserved amino acid residue located in this domain is essential for interaction with both classes of herbicide (15) .
Enzymes of the fatty acid biosynthetic pathway are promising targets for inhibitors that could be used to treat parasitic diseases. The action of fops and dims on wheat (16), Toxoplasma (9) as well as on yeast gene-replacement strains (14, 15, 17) indicates that in all these systems, inhibition of ACC activity leads to a complete inhibition of the organism's growth. On the other hand, these herbicides are not toxic to animal cells, providing a basis for their use in agriculture and potential in medicine. Furthermore, thiolactomycin, an inhibitor of fatty acid elongation, has been shown to prevent the growth of Plasmodium falciparum (7), and triclosan, an inhibitor of enoyl-acyl carrier protein reductase, has been shown to inhibit growth of P. falciparum and T.
gondii (18) .
In this paper we show that the T. gondii apicoplast ACC is sensitive to fops and that its CT activity is targeted by these inhibitors. We also describe in vitro and in vivo systems to screen for new ACC inhibitors.
EXPERIMENTAL PROCEDURES
Various constructs were assembled from cloned cDNA fragments (6) digested with restriction enzymes and ligated appropriately. DNA fragments with engineered restriction sites were obtained using the Expand High-Fidelity PCR system (Roche) to limit the number of PCRrelated errors, cloned into the pGEM-T Easy vector (Promega) and sequenced before further use.
Convenient restriction sites in the multiple cloning sites (MCS) of the cloning vectors were used
Inhibition of Toxoplasma gondii acetyl-CoA carboxylase Jelenska et al. in some constructions. The pPROEX HT based system (GibcoBRL) was used to express Histagged proteins in E. coli. The pRS423-based system using the GAL10 promoter and yeast ACC1 leader and 3'-UTR (14, 17) was used for ACC expression in yeast. The assembly process was monitored by restriction analysis and sequencing selected regions of each construct. DNA was sequenced at the University of Chicago Cancer Research Center Sequencing Facility,. The positions of the cDNA fragments, key restriction sites used in the assembly process, and the structures of the constructs are outlined in Fig.1 . Amino acid compositions of the proteins encoded by these constructs are shown in Table 1 .
T. gondii ACC1 and ACC2 cDNA. ACC cDNA fragments ACC1/Fragment II, ACC1/Fragment III, ACC1/Fragment IV and ACC2/Fragment III were cloned by reverse transcription-PCR into the pGEM-T Easy vector (Promega) as previously described (6) . cDNA fragments ACC1/Fragment V and ACC2/Fragment IV were isolated from a T. gondii cDNA library in pBluescriptSK (+) vector (Stratagene) as previously described (6 Protein expression in E. coli, affinity purification, enzymatic activity and inhibition.
pPROEX HT plasmids carrying various constructs were introduced into E. coli strain DH5α.
Liquid cultures started from fresh transformants grown to OD of approximately 0.8 measured at 600 nm were induced by addition of IPTG to a final concentration of 1 mM. Cells were harvested after 4 -16 hours of culture at room temperature. Protein expression was analyzed by SDS-PAGE using 4-15% gels from BioRad according to the manufacturer's protocol and staining with Coommasie blue. His-tagged proteins were affinity-purified on a Ni-NTA Superflow resin (Qiagen) according to the manufacturer's protocol. Poly(Histidine)-tagged protein protease inhibitor cocktail (Sigma) was added before cell lysis. The ACC activity was assayed by measuring incorporation of 14 C from bicarbonate to acid-stable malonyl-CoA (at 37 °C) and the reverse CT reaction (at 23 and 37 °C) was assayed by measuring transfer of the carboxyl group from [ 14 C]-malonyl-CoA to biotin ester as described previously (15) . The conditions of the reverse CT reaction were such that 10-80% of the substrate was converted within 30-90 minutes.
Inhibitors were added as 20-fold concentrated solutions in 10% DMSO in 0.1 M Tris/HCl, pH 8.0. Imidazole from the affinity column buffer had no effect on either enzymatic activity or on the inhibition patterns. Protein biotinylation was analyzed on Western blots using [ 35 S]-streptavidin as described previously (16) .
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Complementation of the yeast ACC1 null mutation and growth inhibition of yeast genereplacement strains.
These experiments were carried out as described before (14, 15, 17 
RESULTS
An in vitro system to study T. gondii apicoplast ACC using proteins overexpressed in E. coli.
cDNA encoding full length mature (i.e. without the signal/transit peptide) T. gondii plastid ACC1 was assembled from overlapping cDNA fragments cloned by reverse transcriptase-PCR or isolated from a cDNA library (6) . These cDNAs were used to prepare a series of constructs for expression in E. coli of full-length T. gondii ACC1 as well as its fragments containing the CT domain ( Fig. 1 and Table 1 ). All of these peptides were fused to a
His-tag at their N-termini to permit purification by affinity chromatography. Construct ACC1/fl 50% of the malonyl-CoA conversion was due to the enzyme's activity independent of biotin.
Similar biotin-independent CT activity was described previously for E. coli ACC subunits (19) .
ACC1/ct protein was expressed in E. coli at a high level and approximately half of the protein was soluble but the affinity-purified preparation contained multiple shorter polypeptides
( Fig. 2) . Specific activity measured in the reverse reaction varied in different experiments from 1.2 to 4.9 nmole of malony-CoA converted per mg of protein per min. The ACC1/bct protein was also expressed in E. coli at a high level but it was insoluble and could not be analyzed further.
ACC1/ct1-ACC1/ct3 proteins were expressed in E. coli at a very high level, a significant portion of these proteins was soluble and their affinity-purified preparations contained a single major polypeptide (Fig. 2) . A variable fraction of the purified proteins precipitated over time during storage at low temperature or during attempts to concentrate them. The specific activity of these proteins, measured in the reverse CT reaction, varied for different preparations from 0.4 to 23 nmole of malonyl-CoA converted per mg of protein per min, with one preparation of each
protein showing activity at the high end of the range and one at the low end of the range. This variability may reflect some properties of these polypeptides, which are also responsible for their spontaneous precipitation. All three proteins, ACC1/ct1-ACC1/ct3, showed a 10-fold higher specific activity when fresh protein preparations were used at 100-fold lower dilution. These maximum specific activities were similar to specific activities of purified E. coli CT (19) and purified recombinant CT of pea ACC (20) . Such low concentrations of the enzyme were not used for the inhibition studies because of high background variation in the CT assay.
Multiple constructs were prepared in order to overcome potential problems with expressing active Toxoplasma ACC1 and its fragments in E. coli, such as low levels of expression, low protein solubility, purity and stability, improper folding, incomplete modification, variable enzymatic activity. We encountered all of them. It is important to emphasize that despite these problems, the inhibition patterns could be measured reproducibly and were consistent for different protein fragments and their preparations with different specific activities, for both the full ACC reaction and its second half-reaction.
Fops inhibit T. gondii apicoplast ACC activity in vitro but dims do not.
The effect of two fops, haloxyfop and clodinafop, and one dim, sethoxydim, on activity of the apicoplast ACC (ACC1/fl) was tested at concentrations previously shown to affect ACC Inhibition of Toxoplasma gondii acetyl-CoA carboxylase Jelenska et al.
activity in partially purified protein extracts from Toxoplasma tachyzoites (9) . Acetyl-CoA dependent activity of ACC1 decreased dramatically when the concentration of haloxyfop or clodinafop increased from 1 µM to 50 µM, with 50% inhibition at approximately 5 µM (Fig. 3) .
The activity was almost completely inhibited at 50 µM. In contrast, sethoxydim, even at 400 µM, showed no effect on the enzymatic activity. The inhibition profile is similar to that observed previously with crude extracts from whole tachyzoites, suggesting that the fop-sensitive apicoplast ACC is the major source of this enzymatic activity in tachyzoites.
Carboxyltransferase activity of the apicoplast T. gondii ACC is targeted by fops.
Previous results on wheat plastid ACC indicated that target sites for both classes of herbicides are located in a 400-amino acid fragment of the CT domain (14, 17) . However, the T.
gondii ACC1 amino acid sequence is very different from that of the ACCs of grasses (9) and its sensitivity to fops and dims also differs considerably ( (9) and Fig. 3 ). Therefore we determined whether fops target the same domain in the Toxoplasma enzyme and if the second ACC halfreaction is also affected. The CT activity (second half-reaction measured in reverse) of the fulllength ACC1 (construct ACC1/fl) showed the same haloxyfop inhibition profile (Fig. 4a) as the full ACC activity measured for the same protein (Fig. 3a) . However, the CT activity decreased only to 50-60% at 20 µM and the reaction was not inhibited further at higher inhibitor concentrations. In this case, ~50% of the enzyme activity resulted from the biotin-independent decarboxylation of malonyl-CoA, which is not affected by fops (data not shown). Thus, the biotin-dependent part of the CT activity measured is fully sensitive to haloxyfop. Haloxyfop (Fig 3b) and clodinafop (not shown) inhibited the activity of the C-terminal half of the enzyme (ACC1/ct) and sethoxydim had no effect, similar to the whole enzyme (Fig. 4a ). The shortest proteins tested, ACC1/ct2 (Fig 3c) and ACC1/ct3 (not shown), were sensitive to haloxyfop and clodinafop over the same concentration range as longer enzyme fragments and insensitive to dims, although cethoxydim at 400 µM concentration decreased activity to 60%. These results narrow the functional CT domain targeted by fops to the C-terminal third of the enzyme. ACC1
C-terminal fragments showed lower biotin-independent CT activity (20-30%) than the fulllength enzyme and in all cases the fops inhibited their biotin-dependent activity completely.
T. gondii apicoplast ACC complements a yeast ACC1 null mutation.
Synthetic genes consisting of Toxoplasma ACC1 coding regions fused to the yeast GAL10 promoter (galactose-inducible) were tested for their ability to complement a yeast ACC1 null mutation. Constructs ACC1/fl1 -ACC1/fl3 ( Fig. 1 and Table 1 ) were designed to express full-length mature T. gondii apicoplast ACC in yeast. These constructs differ only by the position of the engineered translation start codon. The signal peptide was excluded from these constructs because it is not needed for ACC activity in yeast but it could misdirect the protein.
The translation start codon was placed at three different positions offset by a few amino acids, upstream of the conserved BC domain as described above for the E. coli construct ACC1/fl. All three full-length variants of Toxoplasma apicoplast ACC complemented the yeast mutation and the resulting yeast haploid gene-replacement strains grew as fast as haploid wild-type yeast.
Four synthetic genes (ACC1/ch1-ACC1/ch4, Fig. 1 and Table 1 ) encoding the CT domain of Toxoplasma apicoplast ACC fused to the appropriate N-terminal part (BC and BCC domains) of the wheat cytosolic ACC (resistant to herbicides) were made. These constructs were prepared in parallel, with the fusion site between proteins from different species offset by 20-50 amino acids, to avoid loss of enzymatic activity caused by local incompatibility of the two sequences. Indeed, this approach has proved very useful since only one of the wheat cytosolic/T.
gondii apicoplast chimeras (ACC1/ch3) could replace yeast ACC. The growth of a haploid yeast strain complemented by ACC1/ch3 was poor and the strain was difficult to maintain. After a few passages, the cells died or altered their phenotype with respect to their growth rate and response to fops.
Yeast gene-replacement strains depending on T. gondii apicoplast ACC are sensitive to fops.
We have previously shown that the complementing ACC enzyme confers on the yeast strain its properties with respect to resistance or sensitivity to fops and dims (14, 17 ACC (ACC1/fl1-ACC1/fl3) under full induction had doubling times similar to the wild type yeast (Table 1 ). Full induction of these genes driven by the GAL10 promoter is achieved at high galactose concentration. However, under these conditions no growth inhibition of the genereplacement strains by fops was observed, even though the in vitro study described above confirmed that the apicoplast ACC is sensitive. A similar phenomenon was observed when herbicide-resistant maize plastid ACC was expressed in yeast gene-replacement strains (15) .
The most plausible explanation of this observation is that these strains express high levels of 
T. gondii ACC2 is resistant to fops and dims.
A series of four constructs for expression in E. coli of different ACC2 fragments containing the CT domain (Table 1) were prepared from previously cloned cDNA fragments (6) and analyzed in the same way as described above. Although ACC2/ct1 and ACC2/ct2 proteins Inhibition of Toxoplasma gondii acetyl-CoA carboxylase Jelenska et al.
were expressed at a very low level and ACC2/ct3 and ACC2/ct4 were mostly insoluble, small amounts of ACC2/ct1, ACC2/ct2 and ACC2/ct4 could be purified and tested for enzymatic activity. These protein preparations contained multiple shorter polypeptides. Identity of the fulllength ACC2/ct1 and ACC2/ct2 was confirmed by Western blot analysis using anti-T. gondii ACC2 antibodies. All these proteins showed the expected CT activity measured in the reverse ACC second half-reaction. The specific activity varied from 0.3 to 1.0 nmole of malony-CoA converted per mg of protein per min with the biotin-independent activity accounting for ~10% of the total. The CT activity of ACC2/ct1 and ACC2/ct2 was resistant to both fops and dims at high concentrations (up to 400 µM). This result supports our conclusion that the properties of the apicoplast ACC, and not the cytosolic enzyme, are responsible for Toxoplasma sensitivity to fops.
Two synthetic genes (ACC2/ch1 and ACC2/ch2, Table 1 ) were prepared for expression of chimeric wheat cytosolic/Toxoplasma ACC2 proteins in yeast. However, neither of these complemented the yeast ACC1 null mutation. We have shown recently that fops inhibit T. gondii growth but do not affect human host cells (9) . The parasite growth inhibition correlated well with the in vitro inhibition of its ACC activity. Dims had no effect on Toxoplasma growth nor on its ACC, a clear distinction from the Inhibition of Toxoplasma gondii acetyl-CoA carboxylase Jelenska et al.
DISCUSSION
effect of these compounds on grasses. We have also determined that the parasite has two ACC isozymes: ACC1 located in the apicoplast and ACC2 located in the cytosol (6, 9) , and postulated that ACC1 participating in the apicoplast de novo fatty acid synthesis is sensitive to fops and as such is responsible for the growth inhibition exerted by these compounds.
In this work, we tested this hypothesis by in vitro and in vivo analysis of Toxoplasma ACC1 and ACC2 with respect to their resistance/sensitivity and localization of the sensitivity determinant in the multi-domain enzyme. The in vitro analysis relied on purified ACCs and their CT-containing fragments expressed in E. coli. Several peptides obtained in this way were soluble and enzymatically active in either the full ACC reaction or in the second half-reaction, or both, depending on their structure. The low specific activity of the affinity-purified his-tagged fulllength ACC1 preparations was consistent with their purity and partial biotinylation.
Overexpressing a 250-kDa fully-modified eukaryotic protein in E. coli was a difficult task. A his-tag rather than biotin was used for affinity purification because the latter method, using commercially available products, were ineffective in our attempts to purify other native multidomain ACCs (unpublished results). The results of enzymatic tests, using these full-length ACC1
preparations properly reflect the properties of the native protein as indicated by the substrate dependence of their enzymatic activity. In addition, the inhibition patterns were very similar to those measured for protein preparations extracted from T. gondii and for CT-fragments made in E. coli, which showed both high purity and high substrate-dependent specific activity. Finaly, these results were confirmed by in vivo assays using yeast gene-replacement strains that depend on the activity of full-length T. gondii ACC1 for growth.
The in vivo analysis took advantage of the methodology developed earlier for a similar study of plant ACCs (14, 15, 17) . In this approach, the activity of foreign ACCs is tested by complementation of the yeast ACC1 null mutation and their inhibition is tested by measuring growth of haploid gene-replacement strains, dependent on those foreign ACCs, in the presence of inhibitors. This approach was successfully implemented for Toxoplasma apicoplast ACC, although fop inhibition was detectable only at ACC expression levels limiting yeast growth. A gene-replacement strain with a chimeric wheat cytosolic/Toxoplasma apicoplast ACC grew poorly and was unstable but showed the expected sensitivity to fops.
Sensitivity of the apicoplast Toxoplasma ACC1 to fops was revealed by both methods.
Results of in vitro tests were similar for the full length apicoplast ACC or its fragments containing the CT domain only. On the contrary, the cytosolic isozyme ACC2 was resistant. Both isozymes, ACC1 and ACC2, were resistant to dims. Moreover, the profile of ACC1 inhibition is very similar to that of the crude protein extract isolated from parasites (9) indicating that the apicoplast isozyme contributes the major ACC activity in Toxoplasma tachyzoites. These results, taken together with the sub-cellular localization of the two ACC isozymes (6), support our hypothesis that inhibition of Toxoplasma growth in human fibroblasts by fops is due to inhibition of the apicoplast-localized fatty acid biosynthesis for which ACC1 is a key enzyme.
There is a significant difference in the sensitivity pattern between the wheat (14,17) and T. gondii ((9) and this work) ACCs . Inhibition of the parasite ACC1 requires higher fop concentration and the enzyme is resistant to dims. These differences probably reflect differences in the enzyme structure. The molecular mechanism of fop and dim interaction with the enzyme is not known although we have localized the sensitivity determinant within the wheat plastid ACC to a 400-amino acid region of the CT domain (14) . Here we show that the CT domain of the apicoplast Toxoplasma ACC1 is also a target for fops and that this domain is sufficient to confer sensitivity on a chimeric ACC. We suppose that decarboxylation of biotin by the CT activity is affected by fops because the biotin-independent decarboxylation of malonyl-CoA was insensitive to inhibitors. We recently further reported the importance of a single Ile/Leu residue within the 400 amino acid region: all known resistant ACCs including resistant grass biotypes have a Leu residue at this site while sensitive grass enzymes have an Ile residue, and an Ile to Leu mutation confers resistance to previously sensitive enzymes (15) . The sensitive Toxoplasma ACC1 has a Leu residue at the site. Interestingly, this residue is still important for the interaction with fops, since its mutation to Ile converts the enzyme to fop-resistant (15) .
Studies on the sensitivity of T. gondii ACCs to representative fops and dims carried out to date reveal a good correlation between inhibitor activity against ACC measured using enzyme purified from the parasites or expressed and purified from E. coli, tested in the recombinant yeast system and in living parasites ((9) and this work). The compounds we tested were not specifically designed or selected to affect Toxoplasma. IC 50 values for fops were in the range of 5 µM which are too high for their application as drugs. Stronger specific inhibitors are needed.
Yeast gene-replacement strains seem especially suitable for a large-scale search, because they sequences are for even the most conserved part of the enzyme, the BC domain (9) . For example, the amino acid sequences of T. gondii and P. falciparum ACC1 are more divergent than the wheat cytosolic and plastid isoforms, which differ dramatically in their sensitivity to fops and dims. In order to design effective and specific drugs, it will therefore be necessary to study the ACCs from each parasite, because each may show different sensitivity to inhibitors. Our studies on ACC strongly support the idea that the other steps of the fatty acid biosynthesis pathway in the apicoplast provide promising targets for therapeutic intervention. The positions of cDNA fragments and key restriction sites used in the assembly process are
shown. Cloning of Fragments II-V and the structure of the apicoplast ACC cDNA has been described previously (6) . The His-tag was from vector pPROEX. GAL10 promoter, yeast ACC1 leader and 3'-UTR were as described previously (17) . Amino acid composition of proteins encoded by the constructs is shown in Table 1 . ACC subunit structure and localization of the herbicide (fops and dims) sensitivity determinant in plastid ACC from grasses were described previously (14) . The amino acid site critical for interaction with fops and dims (15) occupied by
Ile in plastid ACC of grasses and Leu in T. gondii ACC1 is indicated. 
Fig. 3. Effect of fops and dims on T. gondii apicoplast ACC activity (full reaction).
The protein tested was encoded by construct ACC1/fl ( Fig. 1 and Table 1 ). The enzymatic activity in the absence of inhibitor was taken as 100%. Averages from two experiments are shown with errors. Average specific activity of enzyme preparations used in these experiments (100% activity) was 0.08 nmoles of malonyl-CoA produced per mg of protein per min. Table 1 . The enzymatic activity in the absence of inhibitor was taken as 100%. Biotinindependent decarboxylation activity in the absence of inhibitors is shown as a white bar. Growth of a strain carrying construct ACC1/fl1 ( Fig. 1 and Table 1 Inhibition of Toxoplasma gondii acetyl-CoA carboxylase Jelenska et al.
